The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: results of the CANA-HF study

Citation
Carbone S, Billingsley HE, Canada JM, et al. Diabetes Metab Res Rev 2020; epub ahead of press.